You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 3, March 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Trial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Pediatric Ophthalmology
 •Retinal/ Chorioretinal Disorders
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

15-Year Outcomes Following Threshold Retinopathy of Prematurity

Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity

Cryotherapy for Retinopathy of Prematurity Cooperative Group*

Arch Ophthalmol. 2005;123:311-318.

Objective  To report the ocular structure and visual acuity outcomes at age 15 years, and the incidence of retinal detachment between 10 and 15 years of age, for patients in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP).

Methods  Subjects were 254 survivors from 291 preterm children with birth weights less than 1251 g and severe (threshold) retinopathy of prematurity (ROP) in one or both eyes, who participated in the CRYO-ROP trial. At age 15 years, unfavorable ocular structure was posterior retinal fold or worse judged by study-certified ophthalmologists. Unfavorable distance visual acuity was 20/200 or worse measured by study-certified testers using Early Treatment of Diabetic Retinopathy Study recognition acuity charts.

Results  Thirty percent of treated eyes and 51.9% of control eyes (P<.001) had unfavorable structural outcomes. Between 10 and 15 years of age, new retinal folds, detachments, or obscuring of the view of the posterior pole occurred in 4.5% of treated and 7.7% of control eyes. Unfavorable visual acuity outcomes were found in 44.7% of treated and 64.3% of control eyes (P<.001).

Conclusion  The benefit of cryotherapy for treatment of threshold ROP, for both structure and visual function, was maintained across 15 years of follow-up. New retinal detachments, even in eyes with relatively good structural findings at age 10 years, suggest value in long-term, regular follow-up of eyes that experience threshold ROP.



*Authors: The Writing Committee served as author for the Cryotherapy for Retinopathy of Prematurity Cooperative Group (CRYO-ROP).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

We Can Aim at Better Results in Coming Years
Subhadra Jalali and Anjli Hussain
Arch Ophthalmol. 2006;124(4):604-605.
EXTRACT | FULL TEXT  

We Can Aim at Better Results in Coming Years—Reply
Earl A. Palmer
Arch Ophthalmol. 2006;124(4):605-606.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Premature for Life
Alistair R. Fielder
Arch Ophthalmol. 2005;123(3):392-394.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinopathy of Prematurity Malpractice Claims: The Ophthalmic Mutual Insurance Company Experience
Day et al.
Arch Ophthalmol 2009;127:794-798.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Early Treatment for Retinopathy of Prematurity
Kamholz et al.
Pediatrics 2009;123:262-269.
ABSTRACT | FULL TEXT  

Plus Disease in Retinopathy of Prematurity: Development of Composite Images by Quantification of Expert Opinion
Chiang et al.
IOVS 2008;49:4064-4070.
ABSTRACT | FULL TEXT  

Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management
Jackson et al.
Arch Ophthalmol 2008;126:493-499.
ABSTRACT | FULL TEXT  

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP)
Mills
Arch Ophthalmol 2007;125:1276-1281.
FULL TEXT  

Interexpert Agreement of Plus Disease Diagnosis in Retinopathy of Prematurity
Chiang et al.
Arch Ophthalmol 2007;125:875-880.
ABSTRACT | FULL TEXT  

Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Heller et al.
Pediatrics 2007;120:1-9.
ABSTRACT | FULL TEXT  

Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002
Todd et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2007;92:F251-F254.
ABSTRACT | FULL TEXT  

Comparison of Current Health, Functional Limitations, and Health Care Use of Young Adults Who Were Born With Extremely Low Birth Weight and Normal Birth Weight
Saigal et al.
Pediatrics 2007;119:e562-e573.
ABSTRACT | FULL TEXT  

Development of astigmatism and anisometropia in preterm children during the first 10 years of life: a population-based study.
Larsson and Holmstrom
Arch Ophthalmol 2006;124:1608-1614.
ABSTRACT | FULL TEXT  

The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years
The Early Treatment for Retinopathy of Prematurity
Br J Ophthalmol 2006;90:1378-1382.
ABSTRACT | FULL TEXT  

We can aim at better results in coming years.
Jalali and Hussain
Arch Ophthalmol 2006;124:604-605.
FULL TEXT  

Diode laser versus cryotherapy in treatment of ROP.
O'Keefe and Kirwan
Br J Ophthalmol 2006;90:402-403.
FULL TEXT  

Premature for Life
Fielder
Arch Ophthalmol 2005;123:392-394.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.